AU2173802A - Inhalative solution formulation containing a tiotropium salt - Google Patents

Inhalative solution formulation containing a tiotropium salt

Info

Publication number: AU2173802A
Authority: AU; Australia
Prior art keywords: formulation containing; solution formulation; tiotropium salt; inhalative solution; inhalative
Prior art date: 2000-10-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

AU2173802A

Inventor

Barbara Niklaus-Humke

Christel Schmelzer

Petra Barth

Karin Drechsel

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boehringer Ingelheim Pharma GmbH and Co KG

Boehringer Ingelheim Pharmaceuticals Inc

Original Assignee

Boehringer Ingelheim Pharma GmbH and Co KG

Boehringer Ingelheim Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-31

Filing date

2001-10-24

Publication date

2002-05-15

2001-10-24 Application filed by Boehringer Ingelheim Pharma GmbH and Co KG, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharma GmbH and Co KG

2002-05-15 Publication of AU2173802A publication Critical patent/AU2173802A/en

Status Pending legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Dispersion Chemistry (AREA)
Otolaryngology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AU2173802A 2000-10-31 2001-10-24 Inhalative solution formulation containing a tiotropium salt Pending AU2173802A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10054036		2000-10-31
PCT/EP2001/012292 WO2002036104A2 (en)	2000-10-31	2001-10-24	Inhalative solution formulation containing a tiotropium salt

Publications (1)

Publication Number	Publication Date
AU2173802A true AU2173802A (en)	2002-05-15

Family

ID=7661723

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU2173802A Pending AU2173802A (en)	2000-10-31	2001-10-24	Inhalative solution formulation containing a tiotropium salt
AU2002221738A Expired AU2002221738B2 (en)	2000-10-31	2001-10-24	Inhalative solution formulation containing a tiotropium salt

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AU2002221738A Expired AU2002221738B2 (en)	2000-10-31	2001-10-24	Inhalative solution formulation containing a tiotropium salt

Country Status (38)

Country	Link
EP (2)	EP1837021A3 (en)
JP (1)	JP4344135B2 (en)
KR (1)	KR100853107B1 (en)
CN (2)	CN101292964A (en)
AR (1)	AR038764A1 (en)
AT (1)	ATE373473T1 (en)
AU (2)	AU2173802A (en)
BG (1)	BG66315B1 (en)
BR (1)	BRPI0115076B8 (en)
CA (1)	CA2426074C (en)
CY (1)	CY1107825T1 (en)
CZ (1)	CZ300794B6 (en)
DE (2)	DE50113037D1 (en)
DK (1)	DK1333819T3 (en)
EA (1)	EA007604B1 (en)
EC (1)	ECSP034541A (en)
EE (1)	EE05314B1 (en)
ES (1)	ES2294045T3 (en)
HR (1)	HRP20030338B1 (en)
HU (1)	HU229411B1 (en)
IL (2)	IL155538A0 (en)
ME (1)	ME00244B (en)
MX (1)	MXPA03003742A (en)
MY (1)	MY138940A (en)
NO (1)	NO332519B1 (en)
NZ (1)	NZ526023A (en)
PE (1)	PE20030092A1 (en)
PL (1)	PL203316B1 (en)
PT (1)	PT1333819E (en)
RS (1)	RS50859B (en)
SA (1)	SA01220482B1 (en)
SI (1)	SI1333819T1 (en)
SK (1)	SK286027B6 (en)
TW (1)	TWI293885B (en)
UA (1)	UA78690C2 (en)
UY (1)	UY26989A1 (en)
WO (1)	WO2002036104A2 (en)
ZA (1)	ZA200302922B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003222791B2 (en) *	2002-04-11	2008-09-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosol formulation for inhalation comprising a tiotropium salt

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1292748C (en) *	2003-03-05	2007-01-03	南昌弘益科技有限公司	Timepidium bromide inhalant powders and their preparing process
EP2319844A1 (en) *	2003-11-03	2011-05-11	Boehringer Ingelheim International GmbH	Tiotropium salts, method for creating same and medicinal formulations containing same
RS20060292A (en) *	2003-11-03	2008-08-07	Boehringer Ingelheim International Gmbh.,	Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
NZ563596A (en)	2005-05-02	2011-01-28	Boehringer Ingelheim Int	Crystalline form of tiotropium bromide anhydrate
EP2044967A1 (en) *	2007-10-01	2009-04-08	Boehringer Ingelheim Pharma GmbH & Co. KG	Atomiser
CN104306361A (en) *	2014-09-24	2015-01-28	万特制药(海南)有限公司	Tiotropium bromide-containing inhalable solution
CN111374963A (en) *	2018-12-31	2020-07-07	天津药业研究院有限公司	Tiotropium solution for inhalation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3931041C2 (en) *	1989-09-16	2000-04-06	Boehringer Ingelheim Kg	Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them
SG45171A1 (en) *	1990-03-21	1998-01-16	Boehringer Ingelheim Int	Atomising devices and methods
DE19536902A1 (en) *	1995-10-04	1997-04-10	Boehringer Ingelheim Int	Miniature fluid pressure generating device
DE19653969A1 (en) *	1996-12-20	1998-06-25	Boehringer Ingelheim Kg	New aqueous pharmaceutical preparation for the production of propellant-free aerosols
DE19847968A1 (en) *	1998-10-17	2000-04-20	Boehringer Ingelheim Pharma	Separate storage of an active material and a solvent comprises a closure cap and a container, with a chamber attached to the unit.

2001
- 2001-10-24 WO PCT/EP2001/012292 patent/WO2002036104A2/en not_active Ceased
- 2001-10-24 BR BRPI0115076A patent/BRPI0115076B8/en not_active IP Right Cessation
- 2001-10-24 DE DE50113037T patent/DE50113037D1/en not_active Expired - Lifetime
- 2001-10-24 PL PL360405A patent/PL203316B1/en unknown
- 2001-10-24 NZ NZ526023A patent/NZ526023A/en not_active IP Right Cessation
- 2001-10-24 DK DK01992567T patent/DK1333819T3/en active
- 2001-10-24 AU AU2173802A patent/AU2173802A/en active Pending
- 2001-10-24 AU AU2002221738A patent/AU2002221738B2/en not_active Expired
- 2001-10-24 ES ES01992567T patent/ES2294045T3/en not_active Expired - Lifetime
- 2001-10-24 AT AT01992567T patent/ATE373473T1/en active
- 2001-10-24 DE DE10152521A patent/DE10152521A1/en not_active Withdrawn
- 2001-10-24 EA EA200300482A patent/EA007604B1/en not_active IP Right Cessation
- 2001-10-24 ME MEP-2008-404A patent/ME00244B/en unknown
- 2001-10-24 EP EP07111499A patent/EP1837021A3/en not_active Withdrawn
- 2001-10-24 HU HU0301378A patent/HU229411B1/en unknown
- 2001-10-24 CN CNA2008100985489A patent/CN101292964A/en active Pending
- 2001-10-24 CZ CZ20031486A patent/CZ300794B6/en unknown
- 2001-10-24 IL IL15553801A patent/IL155538A0/en active IP Right Grant
- 2001-10-24 SK SK527-2003A patent/SK286027B6/en not_active IP Right Cessation
- 2001-10-24 RS YUP-330/03A patent/RS50859B/en unknown
- 2001-10-24 HR HR20030338A patent/HRP20030338B1/en not_active IP Right Cessation
- 2001-10-24 CN CNB018183158A patent/CN100396285C/en not_active Expired - Lifetime
- 2001-10-24 KR KR1020037006013A patent/KR100853107B1/en not_active Expired - Lifetime
- 2001-10-24 MX MXPA03003742A patent/MXPA03003742A/en active IP Right Grant
- 2001-10-24 EE EEP200300203A patent/EE05314B1/en unknown
- 2001-10-24 UA UA2003054959A patent/UA78690C2/en unknown
- 2001-10-24 PT PT01992567T patent/PT1333819E/en unknown
- 2001-10-24 EP EP01992567A patent/EP1333819B1/en not_active Expired - Lifetime
- 2001-10-24 CA CA002426074A patent/CA2426074C/en not_active Expired - Fee Related
- 2001-10-24 JP JP2002538916A patent/JP4344135B2/en not_active Expired - Lifetime
- 2001-10-24 SI SI200130774T patent/SI1333819T1/en unknown
- 2001-10-28 SA SA01220482A patent/SA01220482B1/en unknown
- 2001-10-29 MY MYPI20015000A patent/MY138940A/en unknown
- 2001-10-29 TW TW090126764A patent/TWI293885B/en active
- 2001-10-29 UY UY26989A patent/UY26989A1/en not_active Application Discontinuation
- 2001-10-31 AR ARP010105087A patent/AR038764A1/en not_active Application Discontinuation
- 2001-10-31 PE PE2001001086A patent/PE20030092A1/en not_active Application Discontinuation
2003
- 2003-04-07 EC EC2003004541A patent/ECSP034541A/en unknown
- 2003-04-14 ZA ZA200302922A patent/ZA200302922B/en unknown
- 2003-04-16 BG BG107727A patent/BG66315B1/en unknown
- 2003-04-21 IL IL155538A patent/IL155538A/en unknown
- 2003-04-29 NO NO20031911A patent/NO332519B1/en not_active IP Right Cessation
2007
- 2007-12-07 CY CY20071101562T patent/CY1107825T1/en unknown

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003222791B2 (en) *	2002-04-11	2008-09-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosol formulation for inhalation comprising a tiotropium salt

Also Published As

Publication number	Publication date
ME00244B (en)	2011-05-10
CZ300794B6 (en)	2009-08-12
IL155538A (en)	2008-11-26
IL155538A0 (en)	2003-11-23
AR038764A1 (en)	2005-01-26
PT1333819E (en)	2007-10-29
DE50113037D1 (en)	2007-10-31
HK1060524A1 (en)	2004-08-13
EP1837021A3 (en)	2008-03-19
DK1333819T3 (en)	2007-12-03
NO332519B1 (en)	2012-10-08
CN1473038A (en)	2004-02-04
UY26989A1 (en)	2002-06-20
UA78690C2 (en)	2007-04-25
BR0115076A (en)	2003-07-29
YU33003A (en)	2006-05-25
PE20030092A1 (en)	2003-03-24
ES2294045T3 (en)	2008-04-01
RS50859B (en)	2010-08-31
CN100396285C (en)	2008-06-25
EA200300482A1 (en)	2003-12-25
BRPI0115076B8 (en)	2021-05-25
HU229411B1 (en)	2013-12-30
PL360405A1 (en)	2004-09-06
BG107727A (en)	2004-11-30
ZA200302922B (en)	2004-04-22
SA01220482B1 (en)	2007-07-31
SK5272003A3 (en)	2003-10-07
ECSP034541A (en)	2003-05-26
MXPA03003742A (en)	2004-10-15
CZ20031486A3 (en)	2003-08-13
SK286027B6 (en)	2008-01-07
EA007604B1 (en)	2006-12-29
EP1837021A2 (en)	2007-09-26
SI1333819T1 (en)	2007-12-31
MEP40408A (en)	2011-02-10
TWI293885B (en)	2008-03-01
EP1333819B1 (en)	2007-09-19
NO20031911D0 (en)	2003-04-29
NZ526023A (en)	2005-05-27
HUP0301378A2 (en)	2003-10-28
EP1333819A2 (en)	2003-08-13
JP4344135B2 (en)	2009-10-14
CA2426074A1 (en)	2002-05-10
KR20030060926A (en)	2003-07-16
WO2002036104A2 (en)	2002-05-10
NO20031911L (en)	2003-04-29
HUP0301378A3 (en)	2005-12-28
BRPI0115076B1 (en)	2016-07-26
ATE373473T1 (en)	2007-10-15
PL203316B1 (en)	2009-09-30
DE10152521A1 (en)	2002-07-11
AU2002221738B2 (en)	2007-01-11
EE200300203A (en)	2003-10-15
CA2426074C (en)	2008-12-23
HRP20030338A2 (en)	2005-04-30
JP2004512357A (en)	2004-04-22
CN101292964A (en)	2008-10-29
MY138940A (en)	2009-08-28
WO2002036104A3 (en)	2002-08-01
EE05314B1 (en)	2010-08-16
KR100853107B1 (en)	2008-08-21
CY1107825T1 (en)	2013-06-19
HRP20030338B1 (en)	2011-09-30
BG66315B1 (en)	2013-04-30

Publication	Publication Date	Title
IL147553A0 (en)	2002-08-14	Moxifloxacin formulation containing common salt
EG24139A (en)	2008-08-06	New inhalable powder containing tiotropium
EG24478A (en)	2009-08-03	New inhalable powder containing tiotropium
EG24669A (en)	2010-04-11	Antivral azaindole derivatives
AU8967201A (en)	2002-01-30	Valsartan salts
EG24137A (en)	2008-08-06	Tropane derivatives useful in therapy
PL364223A1 (en)	2004-12-13	Pharmaceutical salts
PL358020A1 (en)	2004-08-09	Novel use for complex fluorides
AU2174102A (en)	2002-05-15	Inhalative solution formulation containing a tiotropium salt
GB0011807D0 (en)	2000-07-05	Formulation for inhalation
AU2002221741A1 (en)	2002-07-18	Inhalative solution formulation containing a tiotropium salt
AU2173802A (en)	2002-05-15	Inhalative solution formulation containing a tiotropium salt
PL371204A1 (en)	2005-06-13	Aerosol formulation for inhalation comprising a tiotropium salt
AU2002221738A1 (en)	2002-07-18	Inhalative solution formulation containing a tiotropium salt
HUP0300808A3 (en)	2005-10-28	Fungicidal formulation containing triazolopyridine derivative
AP2003002783A0 (en)	2003-06-30	Medicament containing activted antihtrombin iii
EP1406592A4 (en)	2010-03-17	A salt/ion pair medicinal aerosol formulation
EP1429732A4 (en)	2005-01-26	A core formulation
GB0013400D0 (en)	2000-07-26	A formulation
GB0019132D0 (en)	2000-09-27	A solution monitor
GB0015079D0 (en)	2000-08-09	Solution for pharmaceutical use
TW459479U (en)	2001-10-11	Agent dispenser for aquarium
CA91072S (en)	2000-12-15	Salt platform
ZA200508282B (en)	2006-09-27	Method of preparing a formulation containing a microdosed active principle

AU2173802A - Inhalative solution formulation containing a tiotropium salt - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (2)

Publications (1)

Family

ID=7661723

Family Applications (2)

Family Applications After (1)

Country Status (38)

Cited By (1)

Families Citing this family (7)

Family Cites Families (5)

Cited By (1)

Also Published As

Similar Documents